FDA.reportPublic FDA data

Nostrilla

Manufacturer
Insight Pharmaceuticals LLC
Effective date
2026-09-04
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
daily-update
Hydrated at
2026-09-11 03:02:02

Label at a glance#

ProductNostrilla
Active ingredientOXYMETAZOLINE HYDROCHLORIDE
Label structure10 sections

Indications and uses

temporarily relieves nasal congestion due to: ▪ a cold ▪ hay fever ▪ upper respiratory allergies ▪ helps clear nasal passages; shrinks swollen membranes ▪ temporarily restores freer breathing through the nose

Dosage and administration

adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24 hour period children under 6 years of age : ask a doctor Squeeze and unscrew to remove the protective cap. Align rail grooves and prime pump by depressing it firmly several times (see illustration on side). Hold bottle with thumb at base an...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredient (per spray)

OTC - ACTIVE INGREDIENT SECTION

oxymetazoline hydrochloride 0.05%

Purpose

OTC - PURPOSE SECTION

Nasal decongestant

Uses

INDICATIONS & USAGE SECTION

  • temporarily relieves nasal congestion due to:
    ▪ a cold
    ▪ hay fever
    ▪ upper respiratory allergies
    ▪ helps clear nasal passages; shrinks swollen membranes
    ▪ temporarily restores freer breathing through the nose

Warnings

WARNINGS SECTION

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • heart disease
  • thyroid disease
  • high blood pressure
  • diabetes
  • trouble urinating due to an enlarged prostate gland

When using this product

OTC - WHEN USING SECTION

  • do not exceed recommended dosage
  • temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge may occur
  • do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
  • use of this container by more than one person may spread infection

Stop use and ask a doctor if

OTC - STOP USE SECTION

symptoms persist

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 6 to under 12 years of age(with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24 hour period
  • children under 6 years of age: ask a doctor

Squeeze and unscrew to remove the protective cap. Align rail grooves and prime pump by depressing it firmly several times (see illustration on side). Hold bottle with thumb at base and nozzle between first and second fingers. With head upright, insert nozzle into nostril. Depress pump two or three times, all the way down, and sniff deeply.

Other Information

OTHER SAFETY INFORMATION

  • store between 20° – 25°C (68° – 77°F). Avoid excessive heat or freezing.
  • keep carton for full drug facts

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzalkonium chloride, edetate disodium, glycerin, polyethylene glycol, povidone, propylene glycol, sodium phosphate dibasic, sodium phosphate monobasic, water

Questions or comments?

OTC - QUESTIONS SECTION

1-800-344-7239

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Nōstrilla® 
Oxymetazoline HCl Nasal Solution
NASAL DECONGESTANT
1/2 FL. OZ (15 mL)

Nōstrilla® Oxymetazoline HCl Nasal Solution NASAL DECONGESTANT 1/2 FL. OZ (15 mL)Nōstrilla® Oxymetazoline HCl Nasal Solution NASAL DECONGESTANT 1/2 FL. OZ (15 mL)

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
e67be450-f8e4-4bc1-88bd-1259d379f55fProduct name120210127
c53f3286-4062-4cf5-8355-399519c639a6Product name120170424
a993dfc5-f219-4460-bde6-30dd724d9ef0Product name120160818
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63736-730-012020-04-10C16284748780-19d75b9d0-e6f2-f424-e053-dadaa90a57ceNostrilla
63736-730-012020-04-10C16284748780-19d75b9d0-e6f2-f424-e053-dadaa90a57ceNostrilla
63736-730-022020-04-10C16284748780-19d75b9d0-e6f2-f424-e053-dadaa90a57ceNostrilla
63736-730-022020-04-10C16284748780-19d75b9d0-e6f2-f424-e053-dadaa90a57ceNostrilla
63736-730-012020-01-31C16284748780-19d75b9d0-e6f2-f424-e053-dadaa90a57ceNostrilla
63736-730-012020-01-31C16284748780-19d75b9d0-e6f2-f424-e053-dadaa90a57ceNostrilla
63736-730-022020-01-31C16284748780-19d75b9d0-e6f2-f424-e053-dadaa90a57ceNostrilla
63736-730-022020-01-31C16284748780-19d75b9d0-e6f2-f424-e053-dadaa90a57ceNostrilla

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Oxymetazoline HydrochlorideACTIVE INGREDIENTK89MJ0S5VY2
OxymetazolineACTIVE MOIETY8VLN5B44ZY2
benzalkonium chlorideINACTIVE INGREDIENTF5UM2KM3W72
glycineINACTIVE INGREDIENTTE7660XO1C2
hydrochloric acidINACTIVE INGREDIENTQTT17582CB2
sorbitolINACTIVE INGREDIENT506T60A25R2
waterINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63736-73063736-730-01, 63736-730-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
NameUNIIKind
OXYMETAZOLINE HYDROCHLORIDEK89MJ0S5VYACTIB
BENZALKONIUM CHLORIDEF5UM2KM3W7IACT
EDETATE DISODIUM7FLD91C86KIACT
GLYCERINPDC6A3C0OXIACT
POLYETHYLENE GLYCOL, UNSPECIFIED3WJQ0SDW1AIACT
POVIDONEFZ989GH94EIACT
PROPYLENE GLYCOL6DC9Q167V3IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FIACT
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSKH7I04HPUUIACT
WATER059QF0KO0RIACT

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
72024-10-25full-release2026-06-01 00:36:42

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 72 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
glycineGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRADERMAL0.5 mgExact identifier — unii candidate
60 equally ranked IID candidates
sorbitolSORBITOL506T60A25RSOLUTION / NASAL25 mg/1mlExact identifier — unii+route
6 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR40 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CTABLET / ORAL163.31 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION / INTRAVENOUS200 mgExact identifier — unii candidate
60 equally ranked IID candidates
benzalkonium chlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SPRAY, METERED / NASAL1 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS3.76 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CCAPSULE, DELAYED RELEASE / ORAL50 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CPOWDER, FOR SUSPENSION / ORAL400 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRADERMAL0.5 mgExact identifier — unii candidate
60 equally ranked IID candidates
sorbitolSORBITOL506T60A25RSOLUTION / NASAL25 mg/1mlExact identifier — unii+route
6 equally ranked IID candidates
glycineGLYCINETE7660XO1CCAPSULE / ORAL62 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CTABLET, CHEWABLE / ORAL267 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CPOWDER, FOR SOLUTION / ORAL0.09 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, SOLUTION / INTRAVENOUS0.42 %w/vExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CCAPSULE, DELAYED RELEASE / ORAL50 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CPOWDER, FOR SOLUTION / ORAL0.09 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CTABLET, CHEWABLE / ORAL267 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CTABLET, ORALLY DISINTEGRATING / ORAL60 mgExact identifier — unii candidate
60 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBSPRAY, METERED / NASALADJ PHExact identifier — unii+route+dosage form
3 equally ranked IID candidates
sorbitolSORBITOL506T60A25RSOLUTION / NASAL25 mg/1mlExact identifier — unii+route
6 equally ranked IID candidates
glycineGLYCINETE7660XO1CTABLET / ORAL163.31 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CSOLUTION / ORAL50 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTABLE, LIPOSOMAL / INTRAVENOUS0.38 %w/vExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CTABLET / ORAL163.31 mgExact identifier — unii candidate
60 equally ranked IID candidates
benzalkonium chlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SPRAY, METERED / NASAL1 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR40 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CPASTE, DENTIFRICE / DENTAL0.34 %w/wExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS0.5 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CCAPSULE, DELAYED RELEASE / ORAL50 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CPOWDER / RESPIRATORY (INHALATION)2 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRADERMAL0.5 mgExact identifier — unii candidate
60 equally ranked IID candidates
benzalkonium chlorideBENZALKONIUM CHLORIDEF5UM2KM3W7SPRAY, METERED / NASAL1 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBSPRAY, METERED / NASALADJ PHExact identifier — unii+route+dosage form
3 equally ranked IID candidates
glycineGLYCINETE7660XO1CCAPSULE / ORAL62 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS10 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS0.5 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS10 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS10 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CPOWDER, FOR SUSPENSION / ORAL400 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS200 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS0.5 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS3.76 mgExact identifier — unii candidate
60 equally ranked IID candidates
sorbitolSORBITOL506T60A25RSPRAY / NASAL49 mgExact identifier — unii+route
6 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, SOLUTION / INTRAVENOUS0.42 %w/vExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CTABLET, ORALLY DISINTEGRATING / ORAL60 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CPOWDER / RESPIRATORY (INHALATION)2 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION / INTRAMUSCULAR68 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CPASTE, DENTIFRICE / DENTAL0.34 %w/wExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, SOLUTION / INTRAVENOUS0.42 %w/vExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CCAPSULE / ORAL62 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CSOLUTION / ORAL50 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS3.76 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION / INTRAVENOUS200 mgExact identifier — unii candidate
60 equally ranked IID candidates
hydrochloric acidHYDROCHLORIC ACIDQTT17582CBSPRAY, METERED / NASALADJ PHExact identifier — unii+route+dosage form
3 equally ranked IID candidates
sorbitolSORBITOL506T60A25RSPRAY / NASAL49 mgExact identifier — unii+route
6 equally ranked IID candidates
glycineGLYCINETE7660XO1CPOWDER / RESPIRATORY (INHALATION)2 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS200 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CPOWDER, FOR SOLUTION / ORAL0.09 mgExact identifier — unii candidate
60 equally ranked IID candidates
glycineGLYCINETE7660XO1CPOWDER, FOR SUSPENSION / ORAL400 mgExact identifier — unii candidate
60 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NostrillaOXYMETAZOLINE HYDROCHLORIDEInsight Pharmaceuticals LLC86217847-8e2b-48cc-b289-4987fd3aa7c32026-09-04WarningsExact identifier
ndc (package): 63736-730-01
ndc (package): 63736-730-02
ndc (product): 63736-730
ndc11 (package): 63736073002
ndc11 (package): 63736073001
spl id: 5ab00067-efa6-fc48-e063-6294a90a6499
spl set id: 86217847-8e2b-48cc-b289-4987fd3aa7c3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.